Renal hyperfiltration, fatty liver index, and the hazards of all-cause and cardiovascular mortality in Finnish men
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Renal hyperfiltration (RHF) and fatty liver are separately associated with adverse health outcomes. In this study, we investigated the mortality hazard of coexisting RHF and fatty liver. METHODS: Middle-aged men from the Kuopio Ischaemic Disease Risk Factor Study (n=1,552) were followed up for a median of 29 years. Associations among RHF, fatty liver index (FLI) score, age, body mass index, smoking status, alcohol consumption, and hypertension status were assessed using logistic regression. Cox proportional hazards models were used to determine the hazard ratios (HRs) for all-cause and cardiovascular disease (CVD) mortality with respect to RHF and fatty liver. RESULTS: Of the men, 5% had RHF (n=73), whereas a majority had fatty liver (n=848). RHF was associated specifically with smoking, and fatty liver was associated specifically with overweight. The all-cause mortality hazard was highest (HR, 1.96; 95% confidence interval [CI], 1.27 to 3.01) among men with RHF and fatty liver (n=33). Among men with RHF but normal FLI (n=40), the HR of all-cause mortality was 1.67 (95% CI, 1.15 to 2.42). Among men with fatty liver but a normal estimated glomerular filtration rate (n=527), the HR of all-cause mortality was 1.35 (95% CI, 1.09 to 1.66). CVD mortality hazard was associated with RHF, but not fatty liver. We detected no interaction effect between RHF and fatty liver for all-cause (synergy index, 0.74; 95% CI, 0.21 to 2.67) or CVD (synergy index, 0.94; 95% CI, 0.34 to 2.60) mortality. CONCLUSIONS: RHF and fatty liver are independently associated with all-cause and CVD mortality.
Abstract
OBJECTIVES: Renal hyperfiltration (RHF) and fatty liver are separately associated with adverse health outcomes. In this study, we investigated the mortality hazard of coexisting RHF and fatty liver. METHODS: Middle-aged men from the Kuopio Ischaemic Disease Risk Factor Study (n=1,552) were followed up for a median of 29 years. Associations among RHF, fatty liver index (FLI) score, age, body mass index, smoking status, alcohol consumption, and hypertension status were assessed using logistic regression. Cox proportional hazards models were used to determine the hazard ratios (HRs) for all-cause and cardiovascular disease (CVD) mortality with respect to RHF and fatty liver. RESULTS: Of the men, 5% had RHF (n=73), whereas a majority had fatty liver (n=848). RHF was associated specifically with smoking, and fatty liver was associated specifically with overweight. The all-cause mortality hazard was highest (HR, 1.96; 95% confidence interval [CI], 1.27 to 3.01) among men with RHF and fatty liver (n=33). Among men with RHF but normal FLI (n=40), the HR of all-cause mortality was 1.67 (95% CI, 1.15 to 2.42). Among men with fatty liver but a normal estimated glomerular filtration rate (n=527), the HR of all-cause mortality was 1.35 (95% CI, 1.09 to 1.66). CVD mortality hazard was associated with RHF, but not fatty liver. We detected no interaction effect between RHF and fatty liver for all-cause (synergy index, 0.74; 95% CI, 0.21 to 2.67) or CVD (synergy index, 0.94; 95% CI, 0.34 to 2.60) mortality. CONCLUSIONS: RHF and fatty liver are independently associated with all-cause and CVD mortality.
참고문헌 (44)
- Cockwell P, "The global burden of chronic kidney disease", Lancet, 395, pp.662~664 (2020)
- Di Angelantonio E, "Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study", BMJ, 341, pp.c4986~ (2010)
- Stevens LA, "Low rates of testing and diagnostic codes usage in a commercial clinical laboratory : evidence for lack of physician awareness of chronic kidney disease", J Am Soc Nephrol, 16, pp.2439~2448 (2005)
- Kim LG, "How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit", Nephrol Dial Transplant, 33, pp.1373~1379 (2018)
- Chronic Kidney Disease Prognosis Consortium, "Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts : a collaborative meta-analysis", Lancet, 375, pp.2073~2081 (2010)
- Kanbay M, "Renal hyperfiltration defined by high estimated glomerular filtration rate : a risk factor for cardiovascular disease and mortality", Diabetes Obes Metab, 21, pp.2368~2383 (2019)
- Paik JM, "Changes in the global burden of chronic liver diseases from 2012 to 2017 : the growing impact of NAFLD", Hepatology, 72, pp.1605~1616 (2020)
- Bellentani S, "The spectrum of liver disease in the general population : lesson from the Dionysos study", J Hepatol, 35, pp.531~537 (2001)
- Fan JG, "Prevalence of and risk factors for fatty liver in a general population of Shanghai, China", J Hepatol, 43, pp.508~514 (2005)
- Brunt EM, "Nonalcoholic steatohepatitis : definition and pathology", Semin Liver Dis, 21, pp.3~16 (2001)
- Mitra S, "Epidemiology of non-alcoholic and alcoholic fatty liver diseases", Transl Gastroenterol Hepatol, 5, pp.16~ (2020)
- Estes C, "Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease", Hepatology, 67, pp.123~133 (2018)
- Blais P, "Nonalcoholic fatty liver disease is underrecognized in the primary care setting", Am J Gastroenterol, 110, pp.10~14 (2015)
- Alexander M, "Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease", BMC Med, 16, pp.130~ (2018)
- Adams LA, "Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases", Gut, 66, pp.1138~1153 (2017)
- Lastra G, "Cardiometabolic syndrome and chronic kidney disease", Curr Diab Rep, 6, pp.207~212 (2006)
- Li G, "Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population", Biochem Med(Zagreb), 22, pp.92~99 (2012)
- Tomaszewski M, "Glomerular hyperfiltration : a new marker of metabolic risk", Kidney Int, 71, pp.816~821 (2007)
- Salonen JT, "Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study", Ann Clin Res, 20, pp.46~50 (1988)
- Ilomäki J, "Relationship between alcohol consumption and myocardial infarction among ageing men using a marginal structural model", Eur J Public Health, 22, pp.825~830 (2012)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Levey AS, "Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values", Clin Chem, 53, pp.766~772 (2007)
- "Glomerular filtration rate, estimated with the CKD-EPI equation from cystatin C concentrations"[URL]
- Bedogni G, "The fatty liver index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
- Jensen T, "Increased serum uric acid over five years is a risk factor for developing fatty liver", Sci Rep, 8, pp.11735~ (2018)
- Salonen JT, "HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men", Circulation, 84, pp.129~139 (1991)
- Sochett EB, "Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes", J Am Soc Nephrol, 17, pp.1703~1709 (2006)
- "ICD-10 version: 2019"[URL]
- Skrondal A, "Interaction as departure from additivity in case-control studies : a cautionary note", Am J Epidemiol, 158, pp.251~258 (2003)
- Rothman KJ, "Synergy and antagonism in cause-effect relationships", Am J Epidemiol, 99, pp.385~388 (1974)
- Andersson T, "Calculating measures of biological interaction", Eur J Epidemiol, 20, pp.575~579 (2005)
- Hosmer DW, "Confidence interval estimation of interaction", Epidemiology, 3, pp.452~456 (1992)
- Singh S, "Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis : a systematic review and meta-analysis of pairedbiopsy studies", Clin Gastroenterol Hepatol, 13, pp.643~654 (2015)
- McPherson S, "Evidence of NAFLD progression from steatosis to fibrosingsteatohepatitis using paired biopsies : implications for prognosis and clinical management", J Hepatol, 62, pp.1148~1155 (2015)
- Yasui K, "Nonalcoholic steatohepatitis and increased risk of chronic kidney disease", Metabolism, 60, pp.735~739 (2011)
- Loomba R, "The global NAFLD epidemic", Nat Rev Gastroenterol Hepatol, 10, pp.686~690 (2013)
- Paik J, "Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease", Liver Int, 39, pp.342~352 (2019)
- Musso G, "Association of non-alcoholic paifatty liver disease with chronic kidney disease : a systematic review and meta-analysis", PLoS Med, 11, pp.e1001680~ (2014)
- Maeda I, "Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men", Clin J Am Soc Nephrol, 6, pp.2462~2469 (2011)
- Park M, "Renal hyperfiltration as a novel marker of all-cause mortality", J Am Soc Nephrol, 26, pp.1426~1433 (2015)
- Afsar B, "Urinary sodium excretion and ambulatory blood pressure findings in patients with hypertension", J Clin Hypertens(Greenwich), 17, pp.200~206 (2015)
- La Vecchia C, "Overweight, obesity, diabetes, and risk of breast cancer : interlocking pieces of the puzzle", Oncologist, 16, pp.726~729 (2011)
- Wetzels JF, "Age-and gender-specific reference values of estimated GFR in Caucasians : the Nijmegen Biomedical Study", Kidney Int, 72, pp.632~637 (2007)
- Ballestri S, "NAFLD as a sexual dimorphic disease : role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk", Adv Ther, 34, pp.1291~1326 (2017)